Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SMERY | NOW |
|---|---|---|
| Price | $32.60 | $136.08 |
| Change today | ▼ 0.43% | ▲ 1.27% |
| Market cap | $139.41B | $140.69B |
| Return, 3 months | -9.3% | +22.9% |
| Return, year to date | +16.8% | -11.2% |
| Return, 1 year | +30.6% | -25.5% |
| P/E (TTM) | 45.3 | 85.1 |
| P/B | 11.4 | 11.2 |
| P/E percentile vs own 5y | – | 26th |
| Dividend yield | 0.50% | – |
| Revenue growth (YoY, latest qtr) | – | +24.0% |
| Net profit growth (YoY) | – | -22.6% |
| Gross margin | – | 74.8% |
| Operating margin | – | 11.4% |
| Net margin | – | 11.3% |
| Return on equity | – | 14.2% |
| Analyst target vs. price | – | +5.4% |
| Analyst buy share | – | 90% |
| RSI (14) | 47 | 52 |
| 30-day volatility | 38.8% | 54.6% |
| Max drawdown, 1 year | -31.5% | -56.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
